TRAIL reduces impaired glucose tolerance and NAFLD in the high-fat diet-fed mouse

Conclusion/interpretation: This study shows for the first time that TRAIL is effective when administered after disease onset. In addition, our data sheds light on TRAIL therapeutic potential not only against impaired glucose tolerance, but also against NAFLD.

Source: Clinical Science - November 22, 2017 Category: Biomedical Science Authors: Bernardi, S., Toffoli, B., Tisato, V., Bossi, F., Biffi, S., Lorenzon, A., Zauli, G., Secchiero, P., Fabris, B. Tags: PublishAheadOfPrint Source Type: research